název organizaceDEBRA International
ZEMĚ PŮVODU ORGANIZACEAustria
OBLAST VÝZKUMUProfessions and applied sciences
STÁDIUM KARIÉRYRecognised Researcher (R2) (PhD holders or equivalent who are not yet fully independent)Established Researcher (R3) (Researchers who have developed a level of independence)Leading Researcher (R4) (Researchers leading their research area or field)
The Innovative Research Grant funding scheme is a new opportunity for researchers within and outside the EB (Epidermolysis bullosa) field to explore innovative ideas in EB that could ultimately accelerate the field of EB research. The call is for:
- Concepts or technology that are novel, or new to EB, that had very limited or zero preliminary evidence for applicability to EB, but where there was a well-argued rationale for testing feasibility based on either understanding of the mechanisms or biology of EB, or parallel evidence from other conditions. The purpose of any grant made will be to gain preliminary evidence of feasibility and relevance.
- Research projects that ultimately benefit patients with EB e.g. improving their life quality (either short-term or long-term).
What is funded
Studies that develop a highly innovative concept with the potential to make a step change in our understanding of:
- how the disease develops, or
- the development of therapeutic or diagnostic capabilities.
- bring in new approaches from other indications to tackle unmet problems in EB,
- test new therapy concepts based on known biology,
- investigate the biological basis for intriguing clinical observations,
- fix technical issues that currently limit therapy efficiency, safety or feasibility.
- Maximum amount 120.000 EUR per project.
- Money can be flexibly utilised for personnel and non-personnel costs.
Between 6 months and 2 years duration.
- Lead applicant must have completed a PhD or an equivalent higher degree.
- Lead and co-applicant are expected to have personal salary support for the duration of the grant.
- Research project needs to fall within DEBRA International's four priority research areas.
- Commercial organisations cannot apply for the grant.